Endometrial Carcinomas: A Review Emphasizing Overlapping and Distinctive Morphological and Immunohistochemical Features

被引:73
作者
Bartosch, Carla [3 ]
Lopes, Jose Manuel [3 ,4 ,5 ]
Oliva, Esther [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Univ Porto IPATIMUP, Ctr Hosp S Joao, Oporto, Portugal
[4] Univ Porto IPATIMUP, Fac Med, Oporto, Portugal
[5] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, Oporto, Portugal
关键词
uterus; endometrium; endometrial carcinoma; endometrioid; serous; clear cell; dedifferentiated; malignant mixed mullerian; lynch-related; FEMALE GENITAL-TRACT; CLEAR-CELL CARCINOMA; NONPOLYPOSIS COLORECTAL-CANCER; UTERINE SEROUS CARCINOMA; E-CADHERIN EXPRESSION; SMOOTH-MUSCLE TUMORS; METASTATIC BREAST-CARCINOMA; SYNCHRONOUS PRIMARY CANCERS; MULLERIAN MESODERMAL TUMOR; BETA-CATENIN EXPRESSION;
D O I
10.1097/PAP.0b013e318234ab18
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
This review focuses on the most common diagnostic pitfalls and helpful morphologic and immunohistochemical markers in the differential diagnosis between the different subtypes of endometrial carcinomas, including: (1) endometrioid versus serous glandular carcinoma, (2) papillary endometrioid (not otherwise specified, villoglandular and nonvillous variants) versus serous carcinoma, (3) endometrioid carcinoma with spindle cells, hyalinization, and heterologous components versus malignant mixed mullerian tumor, (4) high-grade endometrioid versus serous carcinoma, (5) high-grade endometrioid carcinoma versus dedifferentiated or undifferentiated carcinoma, (6) endometrioid carcinoma with clear cells versus clear cell carcinoma, (7) clear cell versus serous carcinoma, (8) undifferentiated versus neuroendocrine carcinoma, (9) carcinoma of mixed cell types versus carcinoma with ambiguous features or variant morphology, (10) Lynch syndrome-related endometrial carcinomas, (11) high-grade or undifferentiated carcinoma versus nonepithelial uterine tumors. As carcinomas in the endometrium are not always primary, this review also discusses the differential diagnosis between endometrial carcinomas and other gynecological malignancies such as endocervical (glandular) and ovarian/peritoneal serous carcinoma, as well as with extra-gynecologic metastases (mainly breast and colon).
引用
收藏
页码:415 / 437
页数:23
相关论文
共 257 条
[1]   Metastasis from breast carcinoma to a tamoxifen-related endometrial polyp [J].
Acikalin, MF ;
Öner, Ü ;
Tekin, B ;
Yavuz, E ;
Cengiz, O .
GYNECOLOGIC ONCOLOGY, 2005, 97 (03) :946-948
[2]   WT1 is differentially expressed in serous, endometrioid, clear cell, and mucinous carcinomas of the peritoneum, fallopian tube, ovary, and endometrium [J].
Acs, G ;
Pasha, T ;
Zhang, PJ .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (02) :110-118
[3]   ENDOMETRIAL CARCINOMA WITH ARGYROPHIL CELLS - A HISTOCHEMICAL AND IMMUNOHISTOCHEMICAL ANALYSIS [J].
AGUIRRE, P ;
SCULLY, RE ;
WOLFE, HJ ;
DELELLIS, RA .
HUMAN PATHOLOGY, 1984, 15 (03) :210-217
[4]   Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium [J].
Al Kushi, A ;
Lim, P ;
Aquino-Parsons, C ;
Gilks, CB .
MODERN PATHOLOGY, 2002, 15 (04) :365-371
[5]  
Al-Brahim Nabeel, 2005, Ann Diagn Pathol, V9, P166, DOI 10.1016/j.anndiagpath.2005.03.003
[6]   WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma [J].
Al-Hussaini, M ;
Stockman, A ;
Foster, H ;
McCluggage, WG .
HISTOPATHOLOGY, 2004, 44 (02) :109-115
[7]   Small cell carcinomas and large cell neuroendocrine carcinomas of the endometrium and cervix: Polypoid tumors and those arising in polyps may have a favorable prognosis [J].
Albores-Saavedra, Jorge ;
Martinez-Benitez, Braulio ;
Luevano, Eduardo .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2008, 27 (03) :333-339
[8]   Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray [J].
Alkushi, A ;
Irving, J ;
Hsu, F ;
Dupuis, B ;
Liu, CL ;
Rijn, M ;
Gilks, CB .
VIRCHOWS ARCHIV, 2003, 442 (03) :271-277
[9]   Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems [J].
Alkushi, A ;
Abdul-Rahman, ZH ;
Lim, P ;
Schulzer, M ;
Coldman, A ;
Kalloger, SE ;
Miller, D ;
Gilks, CB .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (03) :295-304
[10]   Interpretation of p53 immunoreactivity in endometrial carcinoma: Establishing a clinically relevant cut-off level [J].
Alkushi, A ;
Lim, P ;
Coldman, A ;
Huntsman, D ;
Miller, D ;
Gilks, CB .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2004, 23 (02) :129-137